OncoStem Diagnostics Competitors and Similar CompaniesClear all

OncoStem Diagnostics's competitors and similar companies include Mirati Therapeutics, Delcath Systems, Infinity Pharmaceuticals and National Medical Centre.

	OncoStem Diagnostics OncoStem Diagnostics is a diagnostic oncology company focused on discovering and developing novel tests for improved treatment planning.	Mirati Therapeutics Mirati Therapeutics is an oncology company that designs and develops targeted therapies to address the genetic drivers of cancer.	Delcath Systems Delcath Systems is a specialty pharmaceutical and medical device company focused on oncology.	Infinity Pharmaceuticals Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions.	National Medical Centre National Medical Centre is a provider of health care services.
Founding Date	Founding Date 2011	Founding Date 2013	Founding Date 1988	Founding Date 2000	Founding Date 2000
Type	Type Private	Type Subsidiary	Type Public	Type Public	Type Private
Tags	Tags Healthcare medical diagnostics oncology therapy	Tags Healthcare biotech clinical research drug development oncology therapy	Tags Healthcare biotech clinical research drug development medical devices oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare medical diagnostics oncology therapy
Locations	Locations Bengaluru, IN HQ	Locations San Diego, US HQ Zug, CH	Locations New York, US HQ Galway, IE Queensbury, US	Locations Cambridge, US HQ	Locations Karachi, PK HQ
Employees	Employees 24	Employees 666% decrease	Employees 437% decrease	Employees 25	Employees 3283% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 294.6 m	Valuation ($) 726.1 k	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $12.4m (FY, 2022)	Revenue (est.) $85.2m (FY, 2025)	Revenue (est.) $2.6m (FY, 2022)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $600k (FY, 2022)	Cost of goods $11.8m (FY, 2025)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $11.8m (FY, 2022)	Gross profit $73.4m (FY, 2025)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income ($740.9m) (FY, 2022)	Net income $2.7m (FY, 2025)	Net income ($44.4m) (FY, 2022)	Net income N/A
Funding
Total funding raised	Total funding raised $ 7m	Total funding raised N/A	Total funding raised $ 42m	Total funding raised $ 106.6m	Total funding raised N/A